- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有58家主力机构披露2025-06-30报告期持股数据，持仓量总计3053.05万股，占流通A股1.72%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为56.79元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"56.79","date":1756281088,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑赢行业平均水平。
[{"date":"2025.08.28","stock":"0.47","trade":"-0.71","ind":"2.25"},{"date":"2025.08.27","stock":"-1.61","trade":"-2.68","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.28","trade":"-0.03","ind":"0.26"},{"date":"2025.08.25","stock":"0.61","trade":"0.83","ind":"2.26"},{"date":"2025.08.22","stock":"0.24","trade":"-0.41","ind":"2.07"},{"date":"2025.08.21","stock":"0.98","trade":"-0.21","ind":"-0.06"},{"date":"2025.08.20","stock":"0.73","trade":"0.26","ind":"0.89"},{"date":"2025.08.19","stock":"-0.55","trade":"1.38","ind":"-0.12"},{"date":"2025.08.18","stock":"1.57","trade":"1.43","ind":"1.73"},{"date":"2025.08.15","stock":"0.14","trade":"1.01","ind":"1.60"},{"date":"2025.08.14","stock":"-0.21","trade":"-1.00","ind":"-0.87"},{"date":"2025.08.13","stock":"0.09","trade":"-0.20","ind":"1.76"},{"date":"2025.08.12","stock":"-0.11","trade":"-0.53","ind":"0.53"},{"date":"2025.08.11","stock":"0.21","trade":"1.43","ind":"1.46"},{"date":"2025.08.08","stock":"0.09","trade":"0.47","ind":"-0.26"},{"date":"2025.08.07","stock":"-0.21","trade":"-0.92","ind":"-0.18"},{"date":"2025.08.06","stock":"-0.39","trade":"-1.93","ind":"0.64"},{"date":"2025.08.05","stock":"0.12","trade":"-1.17","ind":"0.59"},{"date":"2025.08.04","stock":"-0.32","trade":"0.44","ind":"0.46"},{"date":"2025.08.01","stock":"0.37","trade":"3.37","ind":"-0.17"},{"date":"2025.07.31","stock":"-2.33","trade":"-0.17","ind":"-1.73"}]
云南白药,深证成指,中药指数
压力支撑
该股压力位为56.65元，支撑位为56.16元。
[{"text":"\u538b\u529b\u4f4d","value":"56.65","date":1756310400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"56.16","date":1756310400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.4资金面打败了60%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：08月28日 20:30
| 机构今日流向(万元) | -4185.51 | 机构5日流向(万元) | -18329.65 |
| 机构10日流向(万元) | -25468.37 | 机构20日流向(万元) | -48019.47 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少128712.16万股，其中基金净减仓1家，主力净减仓515家，请投资者中长期谨慎为宜。
截止2025-06-30，共58家主力机构（基金58家），持仓量总计3053.05万股，占流通A股1.72%
其中，基金持仓与2024-12-31相比：
增仓：14家 ，增持 206.68万股
减仓：15家 ，减持 389.86万股
新出现在主力名单中：23家 ，持有122.78万股
从主力名单中消失：538家 ，原持有128651.76万股
其中，基金持仓与2024-12-31相比：
增仓：14家 ，增持 206.68万股
减仓：15家 ，减持 389.86万股
新出现在主力名单中：23家 ，持有122.78万股
从主力名单中消失：538家 ，原持有128651.76万股
消息面诊股
诊断结果：5.5消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 预测云南白药2025年Q2财报数据
2025-08-28 - 云南白药：8月27日获融资买入9616.20万元
2025-08-28 - 沪滇科技合作交流暨重大科技基础设施长江行走进云南白
2025-08-27 - 云南白药：8月26日获融资买入6586.24万元
2025-08-27 - 云南白药：8月25日获融资买入1.35亿元，占当日
2025-08-26 - 6家中国药企跻身全球制药50强！
2025-08-25 - 云南白药：8月22日获融资买入1.21亿元，占当日
2025-08-25 - 行业追踪|中医药市场（8月18日-8月24日）：综
2025-08-24 - 成功率仅2%！医药并购水有多深
2025-08-24 - 医药并购的“AB面”：1/50的生存战与10亿美金
2025-08-24
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-14 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-22 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-01 |
| 利好 | 分红转增 | 10派11.85元(含税) | 2025-04-01 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-01 |
| 一般消息 | 高管变动 | 因已达到法定退休年龄 | 2025-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-18 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-28 |
| 利好 | 分红转增 | 10派12.13元(含税) | 2024-10-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了75%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.08.28","price":"2.25","value":"-2.68"},{"date":"2025.08.27","price":"-1.43","value":"-0.03"},{"date":"2025.08.26","price":"0.26","value":"0.83"},{"date":"2025.08.25","price":"2.26","value":"-0.41"},{"date":"2025.08.22","price":"2.07","value":"-0.21"},{"date":"2025.08.21","price":"-0.06","value":"0.26"},{"date":"2025.08.20","price":"0.89","value":"1.38"},{"date":"2025.08.19","price":"-0.12","value":"1.43"},{"date":"2025.08.18","price":"1.73","value":"1.01"},{"date":"2025.08.15","price":"1.60","value":"-1.00"},{"date":"2025.08.14","price":"-0.87","value":"-0.20"},{"date":"2025.08.13","price":"1.76","value":"-0.53"},{"date":"2025.08.12","price":"0.53","value":"1.43"},{"date":"2025.08.11","price":"1.46","value":"0.47"},{"date":"2025.08.08","price":"-0.26","value":"-0.92"},{"date":"2025.08.07","price":"-0.18","value":"-1.93"},{"date":"2025.08.06","price":"0.64","value":"-1.17"},{"date":"2025.08.05","price":"0.59","value":"0.44"},{"date":"2025.08.04","price":"0.46","value":"3.37"},{"date":"2025.08.01","price":"-0.17","value":"-0.17"},{"date":"2025.07.31","price":"-1.73","value":"0.68"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 佛慈制药 | 188.54% | -3.82% | 5.9分 |
| 2 | 奇正藏药 | 111.77% | 0.00% | 5.7分 |
| 3 | ST香雪 | 46.25% | 5.69% | 4.8分 |
| 4 | 天目药业 | 46.13% | 16.57% | 6.4分 |
| 5 | 达仁堂 | 18.31% | -4.80% | 5.4分 |
| 6 | 新天药业 | 10.40% | -6.47% | 5.4分 |
| 8 | 众生药业 | 6.24% | -5.63% | 6.0分 |
| 10 | 康惠制药 | 5.05% | -3.61% | 5.0分 |
| 12 | 片仔癀 | 3.37% | -3.10% | 5.6分 |
| 14 | 步长制药 | 3.16% | 0.74% | 6.1分 |
| 16 | 佐力药业 | 2.24% | -3.09% | 4.9分 |
| 18 | 云南白药 | 1.94% | -0.57% | 6.5分 |
| 20 | 启迪药业 | 1.41% | -4.16% | 4.2分 |
| 22 | 贵州百灵 | 1.35% | -4.29% | 4.7分 |
| 24 | 中恒集团 | 1.10% | -4.51% | 4.7分 |
| 26 | 寿仙谷 | 0.41% | -1.91% | 5.1分 |
| 28 | 同仁堂 | 0.25% | -2.96% | 4.6分 |
| 30 | 康美药业 | 0.00% | 0.00% | 5.6分 |
| 32 | 白云山 | -0.07% | -2.36% | 5.4分 |
| 34 | 健民集团 | -0.31% | 1.27% | 5.4分 |
| 36 | 莱茵生物 | -0.36% | 0.73% | 5.8分 |
| 38 | 马应龙 | -1.26% | -4.18% | 5.1分 |
| 40 | 千金药业 | -1.71% | -2.68% | 5.6分 |
| 42 | 金花股份 | -1.95% | -6.68% | 5.5分 |
| 44 | 康缘药业 | -2.49% | -8.21% | 5.2分 |
| 46 | 维康药业 | -3.04% | -9.01% | 5.1分 |
| 48 | 华润三九 | -3.61% | -1.69% | 5.6分 |
| 50 | 葵花药业 | -3.71% | -2.52% | 4.7分 |
| 52 | 益盛药业 | -4.05% | -6.18% | 5.0分 |
| 54 | 华神科技 | -4.49% | -4.72% | 5.2分 |
| 56 | 贵州三力 | -4.59% | -3.13% | 5.1分 |
| 58 | 陇神戎发 | -5.26% | -6.39% | 5.3分 |
| 60 | 太极集团 | -7.03% | -3.10% | 4.9分 |
| 62 | 红日药业 | -7.24% | -7.03% | 4.5分 |
| 64 | 华森制药 | -8.38% | -7.45% | 5.4分 |
| 66 | - | -21.92% | -3.26% | 分 |
| 68 | 亚宝药业 | - | -5.51% | 5.0分 |
| 70 | 万邦德 | - | 13.82% | 6.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 10/112 ， 58/112。
[{"date":"2025-03-31","value":"4.86","vol":"2.20"},{"date":"2024-12-31","value":"12.07","vol":"4.81"},{"date":"2024-09-30","value":"10.76","vol":"2.92"},{"date":"2024-06-30","value":"8.05","vol":"1.58"},{"date":"2024-03-31","value":"4.18","vol":"1.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.86 | 12.07 | 10.76 | 8.05 | 4.18 |
| 行业(%) | 2.20 | 4.81 | 2.92 | 1.58 | 1.66 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"31.55","vol":"52.92"},{"date":"2024-12-31","value":"27.90","vol":"52.40"},{"date":"2024-09-30","value":"28.40","vol":"52.75"},{"date":"2024-06-30","value":"29.30","vol":"53.12"},{"date":"2024-03-31","value":"29.98","vol":"53.48"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
31.55 | 27.90 | 28.40 | 29.30 | 29.98 |
| 行业(%) | 52.92 | 52.40 | 52.75 | 53.12 | 53.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/112 ， 18/112。
[{"date":"2025-03-31","value":"0.62","vol":"-6.63"},{"date":"2024-12-31","value":"2.36","vol":"-6.97"},{"date":"2024-09-30","value":"0.76","vol":"-4.57"},{"date":"2024-06-30","value":"0.72","vol":"-4.39"},{"date":"2024-03-31","value":"2.49","vol":"-2.50"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.62 | 2.36 | 0.76 | 0.72 | 2.49 |
| 行业(%) | -6.63 | -6.97 | -4.57 | -4.39 | -2.50 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"13.67","vol":"-36.42"},{"date":"2024-12-31","value":"16.02","vol":"-142.71"},{"date":"2024-09-30","value":"4.93","vol":"63.06"},{"date":"2024-06-30","value":"12.76","vol":"-13.81"},{"date":"2024-03-31","value":"12.12","vol":"78.27"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.67 | 16.02 | 4.93 | 12.76 | 12.12 |
| 行业(%) | -36.42 | -142.71 | 63.06 | -13.81 | 78.27 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/112 ， 4/112。
[{"date":"2025-03-31","value":"0.20","vol":"0.12"},{"date":"2024-12-31","value":"0.75","vol":"0.49"},{"date":"2024-09-30","value":"0.55","vol":"0.37"},{"date":"2024-06-30","value":"0.38","vol":"0.26"},{"date":"2024-03-31","value":"0.19","vol":"0.13"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.75 | 0.55 | 0.38 | 0.19 |
| 行业(次) | 0.12 | 0.49 | 0.37 | 0.26 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.21","vol":"0.60"},{"date":"2024-12-31","value":"4.53","vol":"2.40"},{"date":"2024-09-30","value":"3.41","vol":"1.79"},{"date":"2024-06-30","value":"2.33","vol":"1.23"},{"date":"2024-03-31","value":"1.20","vol":"0.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.21 | 4.53 | 3.41 | 2.33 | 1.20 |
| 行业(次) | 0.60 | 2.40 | 1.79 | 1.23 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"6.58","vol":"0.38"},{"date":"2024-12-31","value":"2.21","vol":"15.45"},{"date":"2024-09-30","value":"8.58","vol":"6.15"},{"date":"2024-06-30","value":"28.25","vol":"11.77"},{"date":"2024-03-31","value":"4.89","vol":"1.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.58 | 2.21 | 8.58 | 28.25 | 4.89 |
| 行业 | 0.38 | 15.45 | 6.15 | 11.77 | 1.42 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.93","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.40","vol":"1.40"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.93 | - | 1.40 | - |
| 行业 | 0.00 | 1.46 | 0.00 | 1.40 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 33/112 ， 46/112。
[{"date":"2025-03-31","value":"2.90","vol":"2.97"},{"date":"2024-12-31","value":"2.66","vol":"2.86"},{"date":"2024-09-30","value":"2.69","vol":"3.22"},{"date":"2024-06-30","value":"2.64","vol":"2.95"},{"date":"2024-03-31","value":"2.77","vol":"2.99"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.90 | 2.66 | 2.69 | 2.64 | 2.77 |
| 行业 | 2.97 | 2.86 | 3.22 | 2.95 | 2.99 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.27","vol":"2.20"},{"date":"2024-12-31","value":"2.04","vol":"2.09"},{"date":"2024-09-30","value":"2.06","vol":"2.40"},{"date":"2024-06-30","value":"2.05","vol":"2.22"},{"date":"2024-03-31","value":"2.17","vol":"2.28"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.27 | 2.04 | 2.06 | 2.05 | 2.17 |
| 行业 | 2.20 | 2.09 | 2.40 | 2.22 | 2.28 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/112 ， 41/112。
[{"date":"2025-03-31","value":"24.81","vol":"33.34"},{"date":"2024-12-31","value":"26.55","vol":"34.08"},{"date":"2024-09-30","value":"27.10","vol":"32.93"},{"date":"2024-06-30","value":"27.55","vol":"33.75"},{"date":"2024-03-31","value":"26.85","vol":"33.01"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
24.81 | 26.55 | 27.10 | 27.55 | 26.85 |
| 行业(%) | 33.34 | 34.08 | 32.93 | 33.75 | 33.01 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.33","vol":"0.72"},{"date":"2024-12-31","value":"0.36","vol":"0.74"},{"date":"2024-09-30","value":"0.37","vol":"3.16"},{"date":"2024-06-30","value":"0.38","vol":"1.63"},{"date":"2024-03-31","value":"0.37","vol":"0.97"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.36 | 0.37 | 0.38 | 0.37 |
| 行业(%) | 0.72 | 0.74 | 3.16 | 1.63 | 0.97 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"28.04","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"30.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"40.94","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"47.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"52.06","blueLineValue":"2.92","type":"YC"}]